Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Passage BIO, Inc. | 100,000 | reported | 27 May 2022 | tx 6+775,100 |
| ALLOS THERAPEUTICS INC | 0 | reported | 04 Sept 2012 | tx 12+347,696−374,508 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 May 2022 | GRANT_AWARD | Passage BIO, Inc. | 100,000 | 0.00 USD | deriv |
| 21 Mar 2022 | PURCHASE | Passage BIO, Inc. | 10,000 | 3.15 USD | |
| 10 Feb 2022 | GRANT_AWARD | Passage BIO, Inc. | 400,000 | 0.00 USD | deriv |
| 21 May 2021 | PURCHASE | Passage BIO, Inc. | 2,000 | 13.12 USD | first after silence |
| 16 Feb 2021 | GRANT_AWARD | Passage BIO, Inc. | 262,000 | 0.00 USD | deriv |
| 03 Mar 2020 | PURCHASE | Passage BIO, Inc. | 1,100 | 18.00 USD | |
| 04 Sept 2012 | TENDER | ALLOS THERAPEUTICS INC | 346,933 | 1.82 USD | |
| 01 Mar 2012 | SALE | ALLOS THERAPEUTICS INC | 4,473 | 1.50 USD | |
| 29 Feb 2012 | SALE | ALLOS THERAPEUTICS INC | 4,505 | 1.52 USD | |
| 28 Feb 2012 | GRANT_AWARD | ALLOS THERAPEUTICS INC | 179,727 | 0.00 USD | |
| 23 Feb 2012 | SALE | ALLOS THERAPEUTICS INC | 2,500 | 1.58 USD | |
| 24 Feb 2012 | SALE | ALLOS THERAPEUTICS INC | 575 | 1.54 USD | |
| 16 Nov 2011 | SALE | ALLOS THERAPEUTICS INC | 300 | 1.43 USD | |
| 15 Nov 2011 | SALE | ALLOS THERAPEUTICS INC | 12,465 | 1.44 USD | |
| 28 Feb 2011 | GRANT_AWARD | ALLOS THERAPEUTICS INC | 67,298 | 0.00 USD | |
| 24 Feb 2011 | SALE | ALLOS THERAPEUTICS INC | 507 | 3.12 USD | |
| 23 Feb 2011 | SALE | ALLOS THERAPEUTICS INC | 2,250 | 3.25 USD | |
| 20 Oct 2010 | GRANT_AWARD | ALLOS THERAPEUTICS INC | 100,671 | 0.00 USD |
1 purchase reported after at least 12 months of silence — most recent on 21 May 2021.